by vmor016 | May 8, 2020 | SMS
On 29 April 2020 the US Food and Drug Administration granted the drug TBAJ-876 approval to proceed to clinical trial for tuberculosis. TBAJ-876 was developed in the Auckland Cancer Society Research Centre by Drs Sutherland, Tong, Choi, Blaser, Conole, Tsang, Denny and...
